Острый тубулоинтерстицальный нефрит


Обсуждаются клинические, лабораторные признаки и подходы к диагностике острого тубулоинтерстициального нефрита.

Литература


1. Rychlik I., Jancova E., Tesar V. et al. The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000. Nephrol. Dial. Transplant. 2004;19(12):3040–3049.
2. Wang Y., Cui Z., Fan M. Retrospective analysis on Chinese patients diagnosed with acute renal failure hospitalized during the last decade (1994–2003). Am. J. Nephrol. 2005;25(5):514–519.
3. Covic A., Schiller A., Volovat C. et al. Epidemiology of renal disease in Romania: a 10 year review of two regional renal biopsy databases. Nephrol. Dial. Transplant. 2006;21(2):419–424.
4. Panichi V., Pasquariello A., Innocenti M. et al. The Pisa experience of renal biopsies, 1977–2005. J. Nephrol. 2007;20(3):329–335.
5. López-Gómez J.M., Rivera F. Spanish Registry of Glomerulonephritis. Renal biopsy findings in acute renal failure in the cohort of patients in the Spanish Registry of Glomerulonephritis. Clin. J. Am. Soc. Nephrol.
2008;3(3):674–681.
6. Cameron J.S. Allergic interstitial nephritis: clinical features and pathogenesis. Q. J. Med. 1988; 66: 97 – 115.
7. Schwarz A., Krause P.H., Kunzendorf U. et al The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis. Clin. Nephrol. 2000; 54(3): 179–190.
8. Pusey C.D., Saltissi D., Bloodworth L. et al. Drug associated acute interstitial nephritis: сlinical and pathological features and the response to high dose steroid therapy. Q. J. Med. 1983; 52: 194 – 211.
9. Montagnac R., Briat C., Schillinger F. et al. Fluoroquinolone induced acute renal failure. General review about a case report with crystalluria due to ciprofloxacin. Nephrol. Ther. 2005; 1(1): 44–51.
10. Hong S., Valderrama E., Mattana J. et al. Vancomycin-induced acute granulomatous interstitial nephritis: therapeutic options. Am. J. Med. Sci. 2007; 334(4): 296–300.
11. Salih S.B., Kharal M., Qahtani M. et al. Acute interstitial nephritis induced by intermittent use of rifampicin in patient with brucellosis. Saudi J. Kidney Dis. Transpl. 2008; 19(3): 450–452.
12. Stratta P., Lazzarich E., Canavese C. et al. Ciprofloxacin crystal nephropathy. Am. J. Kidney Dis. 2007; 50(2): 330–335.
13. Baudeau C., Dard S., Zylberberg H. et al. Rabeprazole induced acute interstitial nephritis. Rev. Med. Interne. 2008; 29(10): 834–836.
14. Simpson I.J., Marshall M.R., Pilmore H. et al. Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases. Nephrology (Carlton). 2006; 11(5): 381–385.
15. Sierra F., Suarez M., Rey M. et al. Systematic review: Proton pump inhibitorassociated acute interstitial nephritis. Aliment. Pharmacol. Ther. 2007; 26(4): 545–553.
16. Lin C.Y., Chiang H. Sodium-valproate-induced interstitial nephritis. Nephron. 1988;48(1):43–46.
17. Martuseviciene G., Kamper A.L., Horn T. A severe case of interstitial nephritis caused by sodium valproate. Ugeskr. Laeger. 2006;168(43):3729–3730.
18. Onishi A., Yamamoto H., Akimoto T. et al. Reversible acute renal failure associated with clomipramine-induced interstitial nephritis. Clin. Exp. Nephrol. 2007;11(3):241–243.
19. Decelle L., Cosyns J.P., Georges B. et al. Acute interstitial nephritis after cocaine sniffing. Clin. Nephrol. 2007;67(2):105–108.
20. Wojciechowski D., Kallakury B., Nouri P. A case of cocaine-induced acute interstitial nephritis. Am. J. Kidney Dis. 2008;52(4):792–795.
21. Gisbert J.P., González-Lama Y., Maté J. 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review. Inflamm. Bowel Dis. 2007;13(5):629–638.
22. Uslu N., Demir H., Saltik-Temizel I.N. et al. Acute tubular injury associated with mesalazine therapy in an adolescent girl with inflammatory bowel disease. Dig. Dis. Sci. 2007;52(11):2926–2629.
23. Corrigan G., Stevens P.E. Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease. Aliment. Pharmacol. Ther. 2000;14(1):1–6.
24. Авдеев В.Г., Фомин В.В., Попова Е.Н. и др. Тубулоинтерстицальный нефрит и фиброзирующий альвеолит, индуцированные сульфасалазином, при язвенном колите. Тер. арх. 2006;78(1):77–79.
25. Van Staa T.P., Travis S., Leufkens H.G. et al. 5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study. Gastroenterology. 2004;126(7): 1733–1739.
26. Ransford R.A.J., Langman M.J.S. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut. 2002; 51:536–539.
27. Farrel R.J., Peppercorn M.A. Ulcerative colitis. Lancet 2002;359:331–340.
28. Kapoor K.G., Bekaii-Saab T. Warfarin-induced allergic interstitial nephritis and leucocytoclastic vasculitis. Intern. Med. J. 2008;38(4):281–283.
29. DeBroe M.E., Elseviers M.M., Bengtsson U. et al. Analgesic nephropathy. Nephrol. Dial. Transplant. 1996;11:2407–2408.
30. Jochum E., Janssen U. Chronic interstitial nephritis in an 18-year-old due to intake of a compound analgesic. Med. Klin. (Munich). 2006; 101(10):830–834.
31. Dixit M.P., Nguyen C., Carson T. et al. Non-steroidal anti-inflammatory drugs-associated acute interstitial nephritis with granular tubular basement membrane deposits. Pediatr. Nephrol. 2008;23(1):145–148.
32. Wolfe M.M., Lichtenstein D.R., Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 1999;340:1888–1899.
33. Komers R., Anderson S., Epstein M. Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors. Am. J. Kidney Dis. 2001; 38:1145–1157.
34. Madeddu G., Quirino T., Carradori S. et al. Renal toxicity in HIVinfected patients receiving HAART including tenofovir. Infez. Med. 2006;14(3):125–134.
35. Schmid S., Opravil M., Moddel M. et al. Acute interstitial nephritis of HIVpositive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies. Virchows Arch. 2007;450(6):665–670.
36. Rho M., Perazella M.A. Nephrotoxicty associated with antiretroviral therapy in HIV-infected patients. Curr. Drug Saf. 2007;2(2):147–154.
37. Manzanera Escribano M.J., Morales Ruiz E., Odriozola Grijalba M. et al. Acute renal failure due to interstitial nephritis after intravesical instillation of BCG. Clin. Exp. Nephrol. 2007;11(3):238–240.
38. Sugimoto T., Yasuda M., Sakaguchi M. et al. Acute interstitial nephritis associated with etanercept. Rheumatol. Int. 2008;28(12):1283–1284.
39. Khurana A. Allergic interstitial nephritis possibly related to sunitinib use. Am. J. Geriatr. Pharmacother. 2007;5(4):341–344.
40. Vanherweghem J.L., Depierreux M., Tielemans C. et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet. 1993;341:387–391.
41. Stengel B., Jones E. End-stage renal insufficiency associated with Chinese herbal consumption in France. Nephrologie. 1998;19:15–20.
42. Lord G.M., Tagore R., Cook T. et al. Nephropathy caused by Chinese herbs in the UK. Lancet. 1999; 354: 481–482.
43. Depierreux M., Van Damme B., Vanden Houte K. et al. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am. J. Kidney Dis. 1994;24:172–180.
44. Reginster F., Jadoul M., van Ypersele de Strihou C. Chinese herbs nephropathy presentation, natural history and fate after transplantation. Nephrol. Dial. Transplant. 1997;12:81–86.


Похожие статьи


Бионика Медиа